The DOI matches its Crossref record; 474 of the 474 references it cites were found in a registry or an index.
Alzheimer’s disease: pathological mechanisms and the beneficial role of melatonin
Open accessAbstract
Alzheimer’s disease (AD) is a highly complex neurodegenerative disorder of the aged that has multiple factors which contribute to its etiology in terms of initiation and progression. This review summarizes these diverse aspects of this form of dementia. Several hypotheses, often with overlapping features, have been formulated to explain this debilitating condition. Perhaps the best‐known hypothesis to explain AD is that which involves the role of the accumulation of amyloid‐β peptide in the brain. Other theories that have been invoked to explain AD and summarized in this review include the cholinergic hypothesis, the role of neuroinflammation, the calcium hypothesis, the insulin resistance hypothesis, and the association of AD with peroxidation of brain lipids. In addition to summarizing each of the theories that have been used to explain the structural neural changes and the pathophysiology of AD, the potential role of melatonin in influencing each of the theoretical processes involved is discussed. Melatonin is an endogenously produced and multifunctioning molecule that could theoretically intervene at any of a number of sites to abate the changes associated with the development of AD. Production of this indoleamine diminishes with increasing age, coincident with the onset of AD. In addition to its potent antioxidant and anti‐inflammatory activities, melatonin has a multitude of other functions that could assist in explaining each of the hypotheses summarized above. The intent of this review is to stimulate interest in melatonin as a potentially useful agent in attenuating and/or delaying AD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Items 201–400 of 474
Plasma chain-breaking antioxidants in Alzheimer's disease, vascular dementia and Parkinson's disease
Foy, C. J. (1999) · QJM · doi:10.1093/qjmed/92.1.39 · Cited by 235
Martins, R. N., Harper, C. G., Stokes, G. B., & Masters, C. L. (1986) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1986.tb00615.x · Cited by 234 · cited 1×
“In response to elevated brain peroxide metabolism, AD brains show increased cerebral glucose-6-phosphate dehydrogenase activity [210], which is the first and rate-limiting enzyme of the pentose phosphate pathway, central to maintenance of the cytosolic pool of NADPH and thus the cellular redox balance.”
BackgroundIntracellular accumulation and resistance to degradation of the Alzheimer amyloid A4/beta protein.
Knauer, M. F., Soreghan, B., Burdick, D., Kosmoski, J., & Glabe, C. G. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.16.7437 · Cited by 233 · cited 1×
“As a consequence of re-internalization from the extracellular space [127, 128] or directly by the cleavage of APP in endosomes generated from the endoplasmic reticulum (ER) or the Golgi apparatus, Ab peptide accumulation also occurs inside neurons leading to trafficking problems, early axonopathy, synaptic loss, and n…”
BackgroundDominguez-Rodriguez, A., Abreu-Gonzalez, P., Sanchez-Sanchez, J. J., Kaski, J. C., & Reiter, R. J. (2010) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2010.00773.x · Cited by 232
Self-citationKitazume, S., Tachida, Y., Oka, R., Shirotani, K., Saido, T. C., & Hashimoto, Y. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.241509198 · Cited by 232
Localization and Cell Association of C1q in Alzheimer's Disease Brain
Afagh, A., Cummings, B. J., Cribbs, D. H., Cotman, C. W., & Tenner, A. J. (1996) · Experimental Neurology · doi:10.1006/exnr.1996.0043 · Cited by 224
Massaad, C. A., Washington, T. M., Pautler, R. G., & Klann, E. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0902714106 · Cited by 223 · cited 1×
“Thus, the overexpression of superoxide dismutase-2 (SOD2), which is localized to mitochondria, scavenges hippocampal superoxide and prevents memory deficits in Tg2576 AD mice [241], which carry both mutant APP and presenilin 1 transgenes [242].”
BackgroundCalmodulin mediates melatonin cytoskeletal effects
Benítez-King, G., & Antón-Tay, F. (1993) · Experientia · doi:10.1007/bf01923944 · Cited by 221
AGE-ASSOCIATED REDUCTION IN NOCTURNAL PINEAL MELATONIN LEVELS IN FEMALE RATS1
REITER, R. J., CRAFT, C. M., JOHNSON, J. E., KING, T. S., RICHARDSON, B. A., VAUGHAN, G. M., & VAUGHAN, M. K. (1981) · Endocrinology · doi:10.1210/endo-109-4-1295 · Cited by 215
Self-citationCaspase-3 Is Enriched in Postsynaptic Densities and Increased in Alzheimer's Disease
Louneva, N., Cohen, J. W., Han, L.-Y., Talbot, K., Wilson, R. S., Bennett, D. A., Trojanowski, J. Q., & Arnold, S. E. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.080434 · Cited by 210
Acute Pharmacology of Melatonin
BARCHAS, J., DACOSTA, F., & SPECTOR, S. (1967) · Nature · doi:10.1038/214919a0 · Cited by 209
Wu, Y.-H., Zhou, J.-N., Van Heerikhuize, J., Jockers, R., & Swaab, D. F. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.06.002 · Cited by 208
Melatonin reduces nitric oxide synthase activity in rat hypothalamus
Bettahi, I., Pozo, D., Osuna, C., Reiter, R. J., Acuña‐Castroviejo, D., & Guerrero, J. M. (1996) · Journal of Pineal Research · doi:10.1111/j.1600-079x.1996.tb00260.x · Cited by 207
Self-citationThe Alzheimer's disease mitochondrial cascade hypothesis: an update
Swerdlow, R. H., & Khan, S. M. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.01.011 · Cited by 206
Gamoh, S., Hashimoto, M., Hossain, S., & Masumura, S. (2001) · Clinical and Experimental Pharmacology and Physiology · doi:10.1046/j.1440-1681.2001.03437.x · Cited by 205
Insulin-like growth factor 1 regulates developing brain glucose metabolism
Cheng, C. M., Reinhardt, R. R., Lee, W.-H., Joncas, G., Patel, S. C., & Bondy, C. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.170008497 · Cited by 204
Parks, J. K., Smith, T. S., Trimmer, P. A., Bennett, J. P., & Parker, W. D. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00112.x · Cited by 199
On the direct scavenging activity of melatonin towards hydroxyl and a series of peroxyl radicals
Galano, A. (2011) · Physical Chemistry Chemical Physics · doi:10.1039/c0cp02801k · Cited by 197
β‐Amyloid fragment 25–35 selectively decreases complex IV activity in isolated mitochondria
Canevari, L., Clark, J. B., & Bates, T. E. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01028-5 · Cited by 196
Pablos, M. I., Agapito, M. T., Gutierrez, R., Recio, J. M., Reiter, R. J., Barlow‐Walden, L., Acuña‐Castroviejo, D., & Menendez‐Pelaez, A. (1995) · Journal of Pineal Research · doi:10.1111/j.1600-079x.1995.tb00178.x · Cited by 194
Self-citationIncreased levels of 4-hydroxynonenal and acrolein in the brain in preclinical Alzheimer disease
Bradley, M. A., Markesbery, W. R., & Lovell, M. A. (2010) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2010.02.016 · Cited by 193 · cited 1×
“Even the brains of preclinical AD individuals, with normal antemortem neuropsychological test scores but abundant AD pathology at autopsy, may exhibit increased levels of the major product of lipid peroxidation, 4-hydroxynonenal, and acrolein, a powerful marker of oxidative damage to protein [211].”
BackgroundAstrocytes: regulation of brain homeostasis via apolipoprotein E
Gee, J. R., & Keller, J. N. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.10.004 · Cited by 193
Husson, I., Mesplès, B., Bac, P., Vamecq, J., Evrard, P., & Gressens, P. (2002) · Annals of Neurology · doi:10.1002/ana.10072 · Cited by 191
The use of melatonin in Alzheimer's disease.
Cardinali, D. P., Brusco, L. I., Liberczuk, C., & Furio, A. M. (2002) · PubMed · Cited by 189
Yasinska, I. M., & Sumbayev, V. V. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00807-x · Cited by 188
The Insulin/Akt Signaling Pathway Is Targeted by Intracellular β-Amyloid
Lee, H.-K., Kumar, P., Fu, Q., Rosen, K. M., & Querfurth, H. W. (2009) · Molecular Biology of the Cell · doi:10.1091/mbc.e08-07-0777 · Cited by 185
Alterations of cerebral metabolism in probable Alzheimer's disease: A preliminary study
Pettegrew, J. W., Panchalingam, K., Klunk, W. E., McClure, R. J., & Muenz, L. R. (1994) · Neurobiology of Aging · doi:10.1016/0197-4580(94)90152-x · Cited by 183
Avdulov, N. A., Chochina, S. V., Igbavboa, U., Warden, C. S., Vassiliev, A. V., & Wood, W. G. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69041746.x · Cited by 180
An immunochemical study of the pyruvate dehydrogenase deficit in Alzheimer's disease brain
Rex Sheu, K., Kim, Y., Blass, J. P., & Weksler, M. E. (1985) · Annals of Neurology · doi:10.1002/ana.410170505 · Cited by 180
Neurotoxins: Free radical mechanisms and melatonin protection
J. Reiter, R., C. Manchester, L., & Tan, D.-X. (2010) · Current Neuropharmacology · doi:10.2174/157015910792246236 · Cited by 179
Self-citationRisk of dementia and AD with prior exposure to NSAIDs in an elderly community-based cohort
Breitner, J. C. S., Haneuse, S. J. P. A., Walker, R., Dublin, S., Crane, P. K., Gray, S. L., & Larson, E. B. (2009) · Neurology · doi:10.1212/wnl.0b013e3181a18691 · Cited by 179
Solano, D. C., Sironi, M., Bonfini, C., Solerte, S. B., Govoni, S., & Racchi, M. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.7.1015 · Cited by 177
Alzheimer's disease: the lipid connection
Hartmann, T., Kuchenbecker, J., & Grimm, M. O. W. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04715.x · Cited by 175
Beyond the Cholinergic Hypothesis: Do Current Drugs Work in Alzheimer's Disease?
Martorana, A., Esposito, Z., & Koch, G. (2010) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1755-5949.2010.00175.x · Cited by 174
Chung, W.-L., Chen, J.-J., & Su, H. (2008) · Journal of Nutrition · doi:10.1093/jn/138.6.1165 · Cited by 172
Conklin, S. M., Gianaros, P. J., Brown, S. M., Yao, J. K., Hariri, A. R., Manuck, S. B., & Muldoon, M. F. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.04.086 · Cited by 172
Aβ as a bioflocculant: implications for the amyloid hypothesis of Alzheimer’s disease
Robinson, S. R., & Bishop, G. M. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00342-6 · Cited by 172
5‐Lipoxygenase gene disruption reduces amyloid‐β pathology in a mouse model of Alzheimer's disease
Firuzi, O., Zhuo, J., Chinnici, C. M., Wisniewski, T., & Praricò, D. (2008) · The FASEB Journal · doi:10.1096/fj.07-9131.com · Cited by 171
Rival, T., Page, R. M., Chandraratna, D. S., Sendall, T. J., Ryder, E., Liu, B., Lewis, H., Rosahl, T., Hider, R., Camargo, L. M., et al. (2009) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2009.06701.x · Cited by 170
Cardiolipin oxidation sets cytochrome c free
Orrenius, S., & Zhivotovsky, B. (2005) · Nature Chemical Biology · doi:10.1038/nchembio0905-188 · Cited by 170
In vitro inhibition of Ca2+/calmodulin-dependent kinase II activity by melatonin
Benítez‐King, G., Ríos, A., Martínez-Hernández, A., & Antón‐Tay, F. (1996) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(96)00025-6 · Cited by 170
Acceleration of Amyloid β-Peptide Aggregation by Physiological Concentrations of Calcium
Isaacs, A. M., Senn, D. B., Yuan, M., Shine, J. P., & Yankner, B. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m602061200 · Cited by 169
Melatonin receptors in rat hippocampus: molecular and functional investigations
Musshoff, U., Riewenherm, D., Berger, E., Fauteck, J., & Speckmann, E. (2002) · Hippocampus · doi:10.1002/hipo.1105 · Cited by 168
Molecular Mechanisms of Melatonin Anticancer Effects
Hill, S. M., Frasch, T., Xiang, S., Yuan, L., Duplessis, T., & Mao, L. (2009) · Integrative Cancer Therapies · doi:10.1177/1534735409353332 · Cited by 168
Feng, Z., Chang, Y., Cheng, Y., Zhang, B., Qu, Z., Qin, C., & Zhang, J. (2004) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2004.00144.x · Cited by 168
Beel, A. J., Sakakura, M., Barrett, P. J., & Sanders, C. R. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2010.03.008 · Cited by 167
Chahbouni, M., Escames, G., Venegas, C., Sevilla, B., García, J. A. G., López, L. C., Muñoz‐Hoyos, A., Molina‐Carballo, A., & Acuña-Castroviejo, D. (2010) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2010.00752.x · Cited by 165
Self-citationPöeggeler, B., Miravalle, L., Zagorski, M. G., Wısnıewskı, T., Chyan, Y., Zhang, Y., Shao, H., Bryant‐Thomas, T., Vidal, R., Frangione, B., et al. (2001) · Biochemistry · doi:10.1021/bi0114269 · Cited by 165
Grammas, P., Samany, P. G., & Thirumangalakudi, L. (2006) · Journal of Alzheimer's Disease · doi:10.3233/jad-2006-9105 · Cited by 165
Beni, S. M., Kohen, R., Reiter, R. J., Tan, D., & Shohami, E. (2004) · The FASEB Journal · doi:10.1096/fj.03-0323fje · Cited by 164
Self-citationMATTSON, M. P. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1306.004 · Cited by 164
Sartori, C., Dessen, P., Mathieu, C., Monney, A., Bloch, J., Nicod, P., Scherrer, U., & Duplain, H. (2009) · Endocrinology · doi:10.1210/en.2009-0425 · Cited by 164
Jou, M., Peng, T., Hsu, L., Jou, S., Reiter, R. J., Yang, C., Chiao, C., Lin, Y., & Chen, C. (2010) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2009.00721.x · Cited by 163
Self-citationJung, K. H., Hong, S., Zheng, H., Lee, H., Lee, D., Lee, D., Lee, S. Y., & Hong, S. (2010) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2010.00748.x · Cited by 162
Inhibition of Amyloid Fibril Formation and Cytotoxicity by Hydroxyindole Derivatives
Cohen, T., Frydman‐Marom, A., Rechter, M., & Gazit, E. (2006) · Biochemistry · doi:10.1021/bi051525c · Cited by 162
Duarte, A. I., Rodrigues‐Santos, P., Oliveira, C. R., Santos, M. S., & Rego, A. C. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.02.016 · Cited by 162
León, J., Escames, G., Rodríguez, M. I., López, L. C., Tapias, V., Entrena, A., Camacho, E., Carriòn, M. D., Gallo, M. Á., Espinosa, A., et al. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04029.x · Cited by 162
Self-citationZheng, F., Qin, C., Chang, Y. S., & Zhang, J. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.08.014 · Cited by 161
Rosales‐Corral, S., Tan, D. X., Reiter, R. J., Valdivia‐Velázquez, M., Martínez‐Barboza, G., Acosta‐Martínez, J. P., & Ortíz, G. G. (2003) · Journal of Pineal Research · doi:10.1034/j.1600-079x.2003.00057.x · Cited by 161
Self-citationMelatonin as a hydroxyl radical scavenger
Stasica, P., Ulanski, P., & Rosiak, J. M. (1998) · Journal of Pineal Research · doi:10.1111/j.1600-079x.1998.tb00387.x · Cited by 160
Wang, X., Zheng, W., Xie, J.-W., Wang, T., Wang, S.-L., Teng, W.-P., & Wang, Z.-Y. (2010) · Molecular Neurodegeneration · doi:10.1186/1750-1326-5-46 · Cited by 159
The neurohormone melatonin inhibits cytokine, mitogen and ionizing radiation induced NF-kappa B.
Mohan, N., Sadeghi, K., Reiter, R. J., & Meltz, M. L. (1995) · PubMed · Cited by 159
Self-citationChen, C., & Bazan, N. G. (2005) · Journal of Neurophysiology · doi:10.1152/jn.00696.2004 · Cited by 157
Nduhirabandi, F., Toit, E. F. D., Blackhurst, D., MARAIS, D. P., & Lochner, A. (2010) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2010.00826.x · Cited by 156
Extrapineal Melatonin: Location and Role within Diffuse Neuroendocrine System
Kvetnoy, I. M. (1999) · The Histochemical Journal · doi:10.1023/a:1003431122334 · Cited by 155
Chung, S., & Han, S. (2003) · Journal of Pineal Research · doi:10.1034/j.1600-079x.2003.00010.x · Cited by 154
Katakura, M., Hashimoto, M., Shahdat, H. M., Gamoh, S., Okui, T., Matsuzaki, K., & Shido, O. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.02.057 · Cited by 152
Increased melatonin 1a‐receptor immunoreactivity in the hippocampus of Alzheimer's disease patients
Savaskan, E., Olivieri, G., Meier, F., Brydon, L., Jockers, R., Ravid, R., Wirz‐Justice, A., & Müller-Spahn, F. (2002) · Journal of Pineal Research · doi:10.1034/j.1600-079x.2002.00841.x · Cited by 152
Role of melatonin in Alzheimer-like neurodegeneration1
Wang, J., & Wang, Z. (2006) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2006.00260.x · Cited by 148
Secretory PLA2-IIA: a new inflammatory factor for Alzheimer's disease
Moses, G. S. D., Jensen, M. D., Lue, L., Walker, D. G., Sun, A. Y., Simonyi, Á., & Sun, G. Y. (2006) · Journal of Neuroinflammation · doi:10.1186/1742-2094-3-28 · Cited by 147
Good sleep, bad sleep! The role of daytime naps in healthy adults
Dhand, R., & Sohal, H. (2006) · Current Opinion in Internal Medicine · doi:10.1097/01.mcp.0000245703.92311.d0 · Cited by 146
Long‐term melatonin administration protects brain mitochondria from aging
Carretero, M., Escames, G., López, L. C., Venegas, C., Dayoub, J. C., García‐Corzo, L., & Acuña-Castroviejo, D. (2009) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2009.00700.x · Cited by 146
Self-citationJekabsone, A., Mander, P. K., Tickler, A. K., Sharpe, M. A., & Brown, G. C. (2006) · Journal of Neuroinflammation · doi:10.1186/1742-2094-3-24 · Cited by 144
Clementi, M. E., Marini, S., Coletta, M., Orsini, F., Giardina, B., & Misiti, F. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.04.041 · Cited by 144
Melatonin Reduces Oxidant Damage and Promotes Mitochondrial Respiration: Implications for Aging
Reiter, R. J., TAN, D. X., Manchester, L. C., & El-Sawi, M. R. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb02096.x · Cited by 141
Self-citationPotential involvement of the transcription factor NF-κB in neurological disorders
Kaltschmidt, B., Baeuerle, P. A., & Kaltschmidt, C. (1993) · Molecular Aspects of Medicine · doi:10.1016/0098-2997(93)90004-w · Cited by 140
In vivo activation of insulin receptor tyrosine kinase by melatonin in the rat hypothalamus
Anhê, G. F., Caperuto, L. C., Pereira‐da‐Silva, M., Souza, L. C., Hirata, A. E., Velloso, L. A., Cipolla‐Neto, J., & Carvalho, C. R. D. O. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02514.x · Cited by 139
S100β Induction of the Proinflammatory Cytokine Interleukin‐6 in Neurons
Li, Y., Barger, S. W., Liu, L., Mrak, R. E., & Griffin, W. S. T. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0740143.x · Cited by 139
Zhou, J., Zhang, S., Zhao, X., & Wei, T. (2008) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2008.00570.x · Cited by 139
Impaired hippocampal long-term potentiation in melatonin MT2 receptor-deficient mice
Larson, J., Jessen, R. E., Uz, T., Arslan, A. D., Kürtüncü, M., Imbesi, M., & Manev, H. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.09.040 · Cited by 137
Functional role of lipoprotein receptors in Alzheimer's disease.
Jaeger, S., & Pietrzik, C. (2008) · Current Alzheimer Research · doi:10.2174/156720508783884675 · Cited by 136
EFFECT OF MELATONIN ON NF‐κB DNA‐BINDING ACTIVITY IN THE RAT SPLEEN
Chuang, J., Mohan, N., Meltz, M. L., & Reiter, R. J. (1996) · Cell Biology International · doi:10.1006/cbir.1996.0091 · Cited by 136
Self-citationHooper, N. M., Keen, J. N., Pappin, D., & Turner, A. J. (1987) · Biochemical Journal · doi:10.1042/bj2470085 · Cited by 135
Reed, T. T., Pierce Jr., W. M., Turner, D. M., Markesbery, W. R., & Allan Butterfield, D. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00478.x · Cited by 135
Pedersen, W. A., Kloczewiak, M. A., & Blusztajn, J. K. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.15.8068 · Cited by 134
Does NSAID use modify cognitive trajectories in the elderly? The Cache County Study
Hayden, K. M., Zandi, P. P., Khachaturian, A. S., Szekely, C. A., Fotuhi, M., Norton, M. C., Tschanz, J. T., Pieper, C. F., Corcoran, C. M., Lyketsos, C. G., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000265223.25679.2a · Cited by 133
Effects of insulin-like growth factor-I on glucose tolerance, insulin levels, and insulin secretion.
Zenobi, P. D., Graf, S., Ursprung, H., & Froesch, E. R. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115796 · Cited by 132
Sberna, G., Sáez‐Valero, J., Beyreuther, K. T., Masters, C. L., & Small, D. H. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.69031177.x · Cited by 132
Huerto‐Delgadillo, L., Antón‐Tay, F., & Benítez‐King, G. (1994) · Journal of Pineal Research · doi:10.1111/j.1600-079x.1994.tb00114.x · Cited by 132
Assembly, Trafficking and Function of γ-Secretase
Kaether, C., Haass, C., & Steiner, H. (2006) · Neurodegenerative Diseases · doi:10.1159/000095267 · Cited by 129
A secreted form of human ADAM9 has an α-secretase activity for APP
Hotoda, N., Koike, H., Sasagawa, N., & Ishiura, S. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00302-9 · Cited by 127
Ha, E., Yim, S., Chung, J., Yoon, K., Kang, I., Cho, Y. H., & Baik, H. H. (2006) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2006.00334.x · Cited by 124
Baydaş, G., Reiter, R. J., Akbulut, M., Tuzcu, M., & Tamer, S. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.05.048 · Cited by 124
Self-citationNeurodegeneration and Inflammation
DeLegge, M. H., & Smoke, A. (2008) · Nutrition in Clinical Practice · doi:10.1177/011542650802300135 · Cited by 124
Petrosillo, G., Moro, N., Ruggiero, F. M., & Paradies, G. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.06.032 · Cited by 124
Quinn, J. F., Kulhanek, D., Nowlin, J., Jones, R., Praticò, D., Rokach, J., & Stackman, R. W. (2005) · Brain Research · doi:10.1016/j.brainres.2005.01.023 · Cited by 122
Melatonin regulates neuronal plasticity in the hippocampus
El‐Sherif, Y., Tesoriero, J., Hogan, M. V., & Wieraszko, A. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10605 · Cited by 121
Jones, C. R., Arai, T., & Rapoport, S. I. (1997) · Neurochemical Research · doi:10.1023/a:1027341707837 · Cited by 120
Aluminum levels in brain in Alzheimer's disease.
Trapp, G. A., Miner, G. D., Zimmerman, R. L., Mastri, A. R., & Heston, L. L. (1978) · PubMed · Cited by 120
Melatonin Promotes Oligodendroglial Maturation of Injured White Matter in Neonatal Rats
Olivier, P., Fontaine, R. H., Loron, G., Van Steenwinckel, J., Biran, V., Massonneau, V., Kaindl, A., Dalous, J., Charriaut-Marlangue, C., Aigrot, M.-S., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007128 · Cited by 119
Sotthibundhu, A., Phansuwan‐Pujito, P., & Govitrapong, P. (2010) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2010.00794.x · Cited by 117
Nicholson, A. M., & Ferreira, A. (2009) · Journal of Neuroscience · doi:10.1523/jneurosci.0862-09.2009 · Cited by 117
Mitochondrial Dynamics in Alzheimerʼs Disease: Opportunities for Future Treatment Strategies
Bonda, D., Wang, X., Perry, G. L., Smith, M. A., & Zhu, X. (2010) · Drugs & Aging · doi:10.2165/11532140-000000000-00000 · Cited by 115
Visualization of NMDA Receptor-Induced Mitochondrial Calcium Accumulation in Striatal Neurons
Peng, T., Jou, M., Sheu, S., & Greenamyre, J. T. (1998) · Experimental Neurology · doi:10.1006/exnr.1997.6599 · Cited by 114
Putative role of neuronal 5-lipoxygenase in an aging brain
Manev, H., Uz, T., Sugaya, K., & Qu, T. (2000) · The FASEB Journal · doi:10.1096/fj.14.10.1464 · Cited by 113
Lahiri, D. K., Chen, D., Ge, Y., Bondy, S. C., & Sharman, E. H. (2004) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2004.00121.x · Cited by 113
Postina, R. (2008) · Current Alzheimer Research · doi:10.2174/156720508783954668 · Cited by 112
Gentleman, S. M., Greenberg, B., Savage, M. J., Noori, M., Newman, S. J., Roberts, G. W., Griffin, W. S. T., & Graham, D. I. (1997) · Neuroreport · doi:10.1097/00001756-199704140-00039 · Cited by 112
The 5-lipoxygenase enzymatic pathway in the mouse brain: Young versus old
Chinnici, C. M., Yao, Y., & Praticò, D. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.06.007 · Cited by 111
Memory Functions as Affected by Electroconvulsive Therapya
Squire, L. R. (1986) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1986.tb51265.x · Cited by 111
Huperzine A protects isolated rat brain mitochondria against β-amyloid peptide
Gao, X., Zheng, C. Y., Yang, L., Tang, X. C., & Zhang, H. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.02.028 · Cited by 110
Aydoğan, S., Yerer, M. B., & Göktaş, A. (2006) · Journal of Endocrinological Investigation · doi:10.1007/bf03345555 · Cited by 110
Aliev, G., Palacios, H. H., Walrafen, B., Lipsitt, A. E., Obrenovich, M. E., & Morales, L. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.03.015 · Cited by 109
Galbete, J. L., Martin, T. R., PERESSINI, E., Modena, P., Bianchi, R., & Forloni, G. (2000) · Biochemical Journal · doi:10.1042/bj3480307 · Cited by 108
5‐lipoxygenase as an endogenous modulator of amyloid beta formation in vivo
Chu, J., & Praticò, D. (2010) · Annals of Neurology · doi:10.1002/ana.22234 · Cited by 108
BACE1 Structure and Function in Health and Alzheimers Disease
Cole, S., & Vassar, R. (2008) · Current Alzheimer Research · doi:10.2174/156720508783954758 · Cited by 107
The Amyloid β Protein Induces Oxidative Damage of Mitochondrial DNA
Bozner, P., Grishko, V. I., LeDoux, S. P., Wilson, G. L., CHYAN, Y.-C., & Pappolla, M. A. (1997) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199712000-00010 · Cited by 107
TGFβ1 regulates the inflammatory response during chronic neurodegeneration
Boche, D., Cunningham, C. M., Docagne, F., Scott, H., & Perry, V. H. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.01.004 · Cited by 107
Tyagi, E., Agrawal, R., Nath, C., & Shukla, R. (2010) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2010.04.041 · Cited by 107
Hoppe, J. B., Frozza, R. L., Horn, A. P., Comiran, R. A., Bernardi, A., Campos, M. M., Battastini, A. M. O., & Salbego, C. G. (2010) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2010.00747.x · Cited by 106
High-Affinity Choline Transporter
Okuda, T., & Haga, T. (2003) · Neurochemical Research · doi:10.1023/a:1022809003997 · Cited by 105
Ghosh, G., De, K., Maity, S., Bandyopadhyay, D., Bhattacharya, S., Reiter, R. J., & Bandyopadhyay, A. (2006) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2006.00386.x · Cited by 104
Self-citationCalamini, B., Santarsiero, B. D., Boutin, J. A., & Mesecar, A. D. (2008) · Biochemical Journal · doi:10.1042/bj20071373 · Cited by 104
Pais, T. F., Figueiredo, C., Peixoto, R. T., Braz, M. H., & Chatterjee, S. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-43 · Cited by 104
Calreticulin–melatonin: An unexpected relationship
Macías, M. J., Escames, G., León, J., Coto‐Montes, A. M., Sbihi, Y., Osuna, A., & Acuña-Castroviejo, D. (2003) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2003.03430.x · Cited by 103
Self-citationPineal and cortical melatonin receptors MT1 and MT2 are decreased in Alzheimer's disease
Brunner, P., Sozer-Topçular, N., Jockers, R., Ravid, R., Angeloni, D., FRASCHINI, F., Eckert, A., Müller-Spahn, F., & Savaskan, E. (2006) · PubMed · doi:10.5167/uzh-49561 · Cited by 103
β-Amyloid selectively augments NMDA receptor-mediated synaptic transmission in rat hippocampus
Wu, J., Anwyl, R., & Rowan, M. J. (1995) · NeuroReport · doi:10.1097/00001756-199511270-00031 · Cited by 101
Association of GSK3B with Alzheimer disease and frontotemporal dementia
Schaffer, B. A. J., Bertram, L., Miller, B. L., Mullin, K., Weintraub, S., Johnson, N., Bigio, E. H., Mesulam, M., Wiedau-Pazos, M., Jackson, G. R., et al. (2008) · Archives of Neurology · doi:10.1001/archneur.65.10.1368 · Cited by 100 · cited 1×
“Finally, GSK-3b, primarily linked to the inactivation of the glycogen synthase, has been also associated with AD and frontotemporal dementia [394] where it is related to microtubule stability because it phosphorylates the microtubule-associated protein tau [395] whose hyperphosphorylation is an early event preceding t…”
BackgroundRodrigues, C. M. P., Solá, S., Brito, M. A., Brondino, C. D., Brites, D. M. T. O., & Moura, J. J. G. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4370 · Cited by 98
García, T. G., Esparza, J. L., Nogués, M. R., Romeu, M., Domingo, J. L., & Gómez, M. (2009) · Hippocampus · doi:10.1002/hipo.20612 · Cited by 97
GSK3β Signalling: Casting a Wide Net in Alzheimer’s Disease
Bhat, R. V., & Budd, S. L. (2002) · Neurosignals · doi:10.1159/000067423 · Cited by 97
Melatonin treatment potentiates neurodegeneration in a rat rotenone Parkinson's disease model
Tapias, V., Cannon, J. R., & Greenamyre, J. T. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22201 · Cited by 97
Aliev, G., Seyidova, D., Lamb, B. T., Obrenovich, M. E., Siedlak, S. L., Vinters, H. V., Friedland, R. P., LaManna, J. C., Smith, M. A., & Perry, G. L. (2003) · Neurological Research · doi:10.1179/016164103101201977 · Cited by 96
Hansen, R. A., Gartlehner, G., Lohr, K. N., & Kaufer, D. (2007) · Drugs & Aging · doi:10.2165/00002512-200724020-00007 · Cited by 96
Bandyopadhyay, S., Goldstein, L. E., Lahiri, D. K., & Rogers, J. T. (2007) · Current Medicinal Chemistry · doi:10.2174/092986707782360060 · Cited by 95
Melatonin affects the metabolism of the β‐amyloid precursor protein in different cell types
Lahiri, D. K. (1999) · Journal of Pineal Research · doi:10.1111/j.1600-079x.1999.tb00575.x · Cited by 94
Melatonin attenuates amyloid beta25–35-induced apoptosis in mouse microglial BV2 cells
Jang, M.-H., Jung, S.-B., Lee, M., Kim, C., Oh, Y.-T., Kang, I., Kim, J., & Kim, E. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.01.003 · Cited by 92
Bi, X., Gall, C. M., Zhou, J., & Lynch, G. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00132-x · Cited by 92
Chow, S.-K., Yu, D. X., MacDonald, C. L., Buibas, M., & Silva, G. A. (2009) · ASN NEURO · doi:10.1042/an20090035 · Cited by 92
Melatonin protects fetal rat brain against oxidative mitochondrial damage
Wakatsuki, A., Okatani, Y., Shinohara, K., Ikenoue, N., Kaneda, C., & Fukaya, T. (2001) · Journal of Pineal Research · doi:10.1034/j.1600-079x.2001.300103.x · Cited by 92
Differentiating Alzheimer disease-associated aggregates with small molecules
Honson, N. S., Johnson, R. L., Huang, W., Inglese, J., Austin, C. P., & Kuret, J. (2007) · Neurobiology of Disease · doi:10.1016/j.nbd.2007.07.018 · Cited by 91
Altered Brain Serotonin Transporter and Associated Glucose Metabolism in Alzheimer Disease
Ouchi, Y., Yoshikawa, E., Futatsubashi, M., Yagi, S., Ueki, T., & Nakamura, K. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.063008 · Cited by 91
Lee, R. K. K., Knapp, S., & Wurtman, R. J. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-03-00940.1999 · Cited by 91
Melatonergic Drugs in Clinical Practice
Hardeland, R., Pöeggeler, B., Srinivasan, V., Trakht, I. N., Pandi-Perumal, S. R., & Cardinali, D. P. (2011) · Arzneimittelforschung · doi:10.1055/s-0031-1296459 · Cited by 91
Current Treatment and Recent Clinical Research in Alzheimer's Disease
Neugroschl, J. A., & Sano, M. (2010) · Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · doi:10.1002/msj.20165 · Cited by 90
Protein Kinase C ϵ Suppresses Aβ Production and Promotes Activation of α-Secretase
Zhu, G., Wang, D., Lin, Y., McMahon, T., Koo, E. H., & Messing, R. O. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5273 · Cited by 90
Song, W., & Lahiri, D. K. (1997) · Journal of Molecular Neuroscience · doi:10.1007/bf02736852 · Cited by 85
Milczarek, R., Hallmann, A., Sokołowska, E., Kaletha, K., & Klimek, J. (2010) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2010.00779.x · Cited by 84
Niikura, T., Hashimoto, Y., Okamoto, T., Abe, Y., Yasukawa, T., Kawasumi, M., Hiraki, T., Kita, Y. A., Terashita, K., Kouyama, K., et al. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-06-01902.2001 · Cited by 84
Superoxide-dependent Oxidation of Melatonin by Myeloperoxidase
Ximenes, V. F., Silva, S. D. O., Rodrigues, M. R., Catalani, L. H., Maghzal, G. J., Kettle, A. J., & Campa, A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506384200 · Cited by 83
Effect of melatonin on cholesterol absorption in rats
Hussain, S. A. (2007) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2006.00415.x · Cited by 82
Khaldy, H. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00133-1 · Cited by 82
The amyloid hypothesis: let sleeping dogmas lie?
Bishop, G. M., & Robinson, S. R. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(02)00050-7 · Cited by 81
Gupta, M. M., Aneja, S., & Kohli, K. (2004) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2004.01.012 · Cited by 80
Brandenburg, L., Konrad, M., Wruck, C. J., Koch, T., Lucius, R., & Pufe, T. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06637.x · Cited by 80
Cui, P., Yu, M., Luo, Z., Dai, M., Han, J., Xiu, R., & Yang, Z.-X. (2007) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2007.00496.x · Cited by 80
Role of Calcium in the Pathogenesis of Alzheimer’s Disease and Transgenic Models
Green, K. N., Smith, I. F., & LaFerla, F. M. (2007) · Springer eBooks · doi:10.1007/978-1-4020-6191-2_19 · Cited by 79
Romero, A., Egea, J., Garcı́a, A. G., & López, M. G. (2010) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2010.00778.x · Cited by 79
Gianotti, L., Pivetti, S., Lanfranco, F., Tassone, F., Navone, F., Vittori, E., Rossetto, R., Gauna, C., Destefanis, S., Grottoli, S., et al. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2001-011441 · Cited by 78
Amyloid-β binds catalase with high affinity and inhibits hydrogen peroxide breakdown
Milton, N. G. N. (1999) · Biochemical Journal · doi:10.1042/bj3440293 · Cited by 77
Melatonin prevents hydrogen peroxide‐induced Bax expression in cultured rat astrocytes
Juknat, A. A., Armanino, M. D. V., Quaglino, A., Fameli, C. I., Mena, M. D., & Kotler, M. L. (2004) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2004.00166.x · Cited by 77
Nitric oxide inhibits insulin-degrading enzyme activity and function through S-nitrosylation
Cordes, C. M., Bennett, R. G., Siford, G. L., & Hamel, F. G. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.12.006 · Cited by 77
Influence of melatonin on free radical‐induced changes in rat pancreatic beta‐cells in vitro
Ebelt, H., Peschke, D., Brömme, H., Mörke, W., Blume, R., & Peschke, E. (2000) · Journal of Pineal Research · doi:10.1034/j.1600-079x.2001.280201.x · Cited by 76
Fraser, D. A., Arora, M., Bohlson, S. S., Lozano, E., & Tenner, A. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m605741200 · Cited by 74
Melatonin reduces amyloid β‐induced apoptosis in pheochromocytoma (PC12) cells
Feng, Z., & Zhang, J. (2004) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2004.00164.x · Cited by 74
ROCK, PAK, and Toll of synapses in Alzheimer’s disease
Salminen, A., Suuronen, T., & Kaarniranta, K. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.04.148 · Cited by 71
Functional Aspects of Redox Control During Neuroinflammation
Rosales‐Corral, S., Reiter, R. J., Tan, D., Ortiz, G. G., & López-Armas, G. D. C. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2629 · Cited by 70
Self-citationGanapathy, P. S., Moister, B., Roon, P., Mysona, B. A., Duplantier, J., Dun, Y., Moister, T. K. V. E., Farley, M. J., Prasad, P. D., Liu, K., et al. (2009) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.09-3402 · Cited by 70
Peschke, E., Schucht, H., & Mühlbauer, E. (2010) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2010.00804.x · Cited by 69
Benítez‐King, G., Túnez, I., Bellon, A., Ortíz, G. G., & Antón-Tay, F. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00085-2 · Cited by 69
Spuch, C., Antequera, D., Fernández‐Bachiller, M. I., Rodríguez-Franco, M. I., & Carro, E. (2009) · Neurotoxicity Research · doi:10.1007/s12640-009-9121-2 · Cited by 69
Inhibitors of protein aggregation and toxicity
Amijee, H., Madine, J., Middleton, D. A., & Doig, A. J. (2009) · Biochemical Society Transactions · doi:10.1042/bst0370692 · Cited by 69
Lichtenthaler, S. F., Beher, D., Grimm, H. S., Wang, R., Shearman, M. S., Masters, C. L., & Beyreuther, K. T. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.032395699 · Cited by 69
Mandal, P. K., & Pettegrew, J. W. (2004) · Neurochemical Research · doi:10.1007/s11064-004-7035-1 · Cited by 68
Pinealectomy causes hippocampal CA1 and CA3 cell loss: Reversal by melatonin supplementation
Butte, M. D., & Pappas, B. A. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.12.004 · Cited by 67
Papavasiliou, P. S. (1972) · JAMA · doi:10.1001/jama.1972.03200140072031 · Cited by 67
Redox Properties of Met35in Neurotoxic β-Amyloid Peptide. A Molecular Modeling Study
Pogocki, D., & Schöneich, C. (2002) · Chemical Research in Toxicology · doi:10.1021/tx0101550 · Cited by 67
Quevedo, C., Alcázar, A., & Salinas, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000238200 · Cited by 67
Das, A., Belagodu, A. P., Reiter, R. J., Ray, S. K., & Banik, N. L. (2008) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2008.00582.x · Cited by 67
Self-citationGałecki, P., Szemraj, J., Bartosz, G., Bieńkiewicz, M., Gałecka, E., Florkowski, A., Lewiñski, A., & Karbownik‐Lewińska, M. (2010) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2010.00754.x · Cited by 67
Mechanisms of N‐methyl‐ d ‐Aspartate Receptor Inhibition by Melatonin In the Rat Striatum
Escames, G., León, J., López, L. C., & Acuña-Castroviejo, D. (2004) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2004.01250.x · Cited by 67
Self-citationMelatonin lowers excitability of guinea pig hippocampal neurons in vitro
Zeise, M. L., & Semm, P. (1985) · Journal of Comparative Physiology A · doi:10.1007/bf00611091 · Cited by 66
Catalytic Antioxidants and Neurodegeneration
Golden, T. R., & Patel, M. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2008.2256 · Cited by 65
Lue, L., Walker, D. G., Jacobson, S. A., & Sabbagh, M. N. (2009) · Future Neurology · doi:10.2217/14796708.4.2.167 · Cited by 64
Feng, Z., & Zhang, J. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.03.007 · Cited by 64
Mitochondria, Mitochondrial DNA and Alzheimers Disease. What Comes First?
Mancuso, M., Orsucci, D., Siciliano, G., & Murri, L. (2008) · Current Alzheimer Research · doi:10.2174/156720508785908946 · Cited by 63
The neuroprotective role of melatonin against amyloidβpeptide injected mice
Masilamoni, J. G., Jesudason, E. P., Dhandayuthapani, S., Ashok, B. S., Vignesh, S., Walter, C. E. J., Paul, S. F. D., & Rajadas, J. (2008) · Free Radical Research · doi:10.1080/10715760802277388 · Cited by 63
Kong, P., Byun, J.-S., Lim, S.-Y., Lee, J.-J., Hong, S. J., Kwon, K.-J., & Kim, S. (2008) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2008.12.2.37 · Cited by 63
Skribanek, Z., Baláspiri, L., & Mák, M. (2001) · Journal of Mass Spectrometry · doi:10.1002/jms.243 · Cited by 62
Ling, Z.-Q., Tian, Q., Wang, L., Fu, Z., Wang, X., Wang, Q., & Wang, J. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-0949 · Cited by 61
A Novel Endogenous Indole Protects Rodent Mitochondria and Extends Rotifer Lifespan
Pöeggeler, B., Sambamurti, K., Siedlak, S. L., Perry, G. L., Smith, M. A., & Pappolla, M. A. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010206 · Cited by 61
Melatonin and Biological Rhythms
Pévet, P. (2000) · Neurosignals · doi:10.1159/000014640 · Cited by 61
Calcium‐Dependent Effects of Melatonin Inhibition of Glutamatergic Response in Rat Striatum
Escames, G., Macías, M., León, J., García, J. J., Khaldy, H., Martı́n, M., Vives, F., & Acuña-Castroviejo, D. (2001) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.2001.00656.x · Cited by 61
Self-citationAlzheimer's disease and type 2 diabetes mellitus: the cholinesterase connection?
Sridhar, G. R., Thota, H., Allam, A. R., Babu, C. S., Akula, S. P., & Divakar, C. (2006) · Lipids in Health and Disease · doi:10.1186/1476-511x-5-28 · Cited by 61
Challenging the Cholinergic Hypothesis in Alzheimer Disease
Davies, P. (1999) · JAMA · doi:10.1001/jama.281.15.1433 · Cited by 60
Melatonin agonists and insomnia
Ferguson, S. A., Rajaratnam, S. M. W., & Dawson, D. E. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.1 · Cited by 60
Greilberger, J., Fuchs, D., Leblhuber, F., Greilberger, M., Wintersteiger, R., & Tafeit, E. (2010) · PubMed · Cited by 59
Viswanathan, S., Ling, E., Lu, J., & Kaur, C. (2009) · Glia · doi:10.1002/glia.20940 · Cited by 59
Lecanu, L., Greeson, J., & Papadopoulos, V. (2005) · Pharmacology · doi:10.1159/000088929 · Cited by 59
Pyruvate protection against β‐amyloid‐induced neuronal death: Role of mitochondrial redox state
Alvarez, G., Ramos, M., Ruiz, F. H., Satrústegui, J., & Bogónez, E. (2003) · Journal of Neuroscience Research · doi:10.1002/jnr.10648 · Cited by 58
Cited by
Melatonin as an antioxidant: under promises but over delivers
Reiter, R. J., Mayo, J. C., Tan, D., Sainz, R. M., Alatorre‐Jimenez, M., & Qin, L. (2016) · Journal of Pineal Research · doi:10.1111/jpi.12360 · Cited by 1,703
Self-citationExtrapineal melatonin: sources, regulation, and potential functions
Acuña-Castroviejo, D., Escames, G., Venegas, C., Díaz-Casado, M. E., Lima-Cabello, E., López, L. C., Rosales-Corral, S., Tan, D.-X., & Reiter, R. J. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1579-2 · Cited by 1,076
Self-citationOn the free radical scavenging activities of melatonin's metabolites, AFMK and AMK
Galano, A., Tan, D. X., & Reiter, R. J. (2013) · Journal of Pineal Research · doi:10.1111/jpi.12010 · Cited by 795
Self-citationMauriz, J. L., Collado, P. S., Veneroso, C., Reiter, R. J., & González‐Gallego, J. (2013) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2012.01014.x · Cited by 626
Self-citationMelatonin: Exceeding Expectations
Reiter, R. J., Tan, D. X., & Galano, A. (2014) · Physiology · doi:10.1152/physiol.00011.2014 · Cited by 605
Self-citation
Metadata
- Authors
- Rosales‐Corral, S. A., Acuña‐Castroviejo, D., Coto‐Montes, A., Boga, J. A., Manchester, L. C., Fuentes‐Broto, L., Korkmaz, A., Ma, S., Tan, D. X., & Reiter, R. J.
- Venue
- Journal of Pineal Research
- Publisher
- Wiley
- Published
- 2011-11-23
- Volume
- 52
- Issue
- 2
- Pages
- 167-202
- ISSN
- 0742-3098 (ISSN-L)
- 1600-079X
- OpenAlex
- W1492774743
- Cited by
- 294
- References
- 474
- FWCI
- 16.18
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.